NO992008L - Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer - Google Patents
Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromerInfo
- Publication number
- NO992008L NO992008L NO992008A NO992008A NO992008L NO 992008 L NO992008 L NO 992008L NO 992008 A NO992008 A NO 992008A NO 992008 A NO992008 A NO 992008A NO 992008 L NO992008 L NO 992008L
- Authority
- NO
- Norway
- Prior art keywords
- syndromes
- estrogen
- enantiomers
- cis
- prevention
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/74—Benzo[b]pyrans, hydrogenated in the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse ved- rører terapeutisk aktive forbindelser med formel (I) (D en fremgangsmåte for fremstilling av de samme forbindelsene, og farmasøytiske preparater som omfatter forbindelsene. De nye forbindelsene kan anvendes ved forhindring eller behandling av østro- genrelaterte sykdommer eller syndromer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK120296 | 1996-10-28 | ||
PCT/DK1997/000482 WO1998018775A1 (en) | 1996-10-28 | 1997-10-28 | Novel (+)-enantiomers of cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO992008D0 NO992008D0 (no) | 1999-04-27 |
NO992008L true NO992008L (no) | 1999-06-25 |
Family
ID=8102133
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO992008A NO992008L (no) | 1996-10-28 | 1999-04-27 | Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0934298A1 (no) |
JP (1) | JP2001502707A (no) |
AU (1) | AU4771997A (no) |
CA (1) | CA2269970A1 (no) |
IL (1) | IL129624A0 (no) |
NO (1) | NO992008L (no) |
WO (1) | WO1998018775A1 (no) |
ZA (1) | ZA979644B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000039120A2 (en) * | 1998-12-30 | 2000-07-06 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
CO5251465A1 (es) | 2000-01-26 | 2003-02-28 | Pfizer Prod Inc | Composiciones y procedimientos para tratar la osteoporosis y reducir el colesterol |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
ATE532777T1 (de) | 2004-09-21 | 2011-11-15 | Marshall Edwards Inc | Substituierte chromanderivate, medikamente und anwendungen in der therapie |
AU2008229617A1 (en) * | 2007-03-16 | 2008-09-25 | Novogen Research Pty Ltd | Method for inducing autophagy |
CA2816322A1 (en) | 2010-11-01 | 2012-05-10 | Marshall Edwards, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
AU2016215515B2 (en) | 2015-02-02 | 2020-04-30 | Mei Pharma, Inc. | Combination therapies |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3340276A (en) * | 1964-04-01 | 1967-09-05 | Ciba Geigy Corp | 3, 4-diphenyl-chromans |
DE1543749A1 (de) * | 1966-02-16 | 1969-12-11 | Merck Ag E | Verfahren zur Herstellung von 3,4-cis-4-Aryl-isoflavanen |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
HUP9702244A3 (en) * | 1995-01-13 | 1999-12-28 | Novo Nordisk As | Use of 3,4-diphenyl chromans for manufacture of a pharmaceutical composition for treatment or prophylaxis of gynaecological disorders |
-
1997
- 1997-10-18 ZA ZA9709644A patent/ZA979644B/xx unknown
- 1997-10-28 IL IL12962497A patent/IL129624A0/xx unknown
- 1997-10-28 EP EP97910263A patent/EP0934298A1/en not_active Withdrawn
- 1997-10-28 WO PCT/DK1997/000482 patent/WO1998018775A1/en not_active Application Discontinuation
- 1997-10-28 CA CA002269970A patent/CA2269970A1/en not_active Abandoned
- 1997-10-28 AU AU47719/97A patent/AU4771997A/en not_active Abandoned
- 1997-10-28 JP JP10519941A patent/JP2001502707A/ja active Pending
-
1999
- 1999-04-27 NO NO992008A patent/NO992008L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO992008D0 (no) | 1999-04-27 |
AU4771997A (en) | 1998-05-22 |
IL129624A0 (en) | 2000-02-29 |
JP2001502707A (ja) | 2001-02-27 |
WO1998018775A1 (en) | 1998-05-07 |
CA2269970A1 (en) | 1998-05-07 |
ZA979644B (en) | 1998-04-28 |
EP0934298A1 (en) | 1999-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO179582C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive hydroksamsyre- og N-hydroksyurinstoff-derivater | |
AU563748B2 (en) | Quinolone carboxylic acids | |
ATE233250T1 (de) | Saccharinderivate als proteolytische enzyminhibitoren | |
RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
NO992003L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992008L (no) | Nye (+)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992010L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992009L (no) | Nye trans-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992007L (no) | Nye (-)-enantiomerer av cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992005L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992006L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992002L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
NO992004L (no) | Nye cis-3,4-kromanderivater som kan anvendes ved forhindring eller behandling av °strogenrelaterte sykdommer eller syndromer | |
ES2059204T3 (es) | Derivados del acido hidroxamico inhibidores de lipoxigenasa. | |
DK0714908T3 (da) | Nye 17-(3-imino-2-alkylproenyl)-5beta, 14beta-androstanderivater, der er aktive i det cardiovaskulære system, fremgansmåder | |
RU93030824A (ru) | Лекарственное средство для лечения псориаза "дермапихтол" | |
RU93055683A (ru) | Ингибиторы вич-протеазы, способ их получения, их использование, композиция | |
RU93055680A (ru) | Ингибиторы вич-протеазы, способ получения, их использование, композиция |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |